850 related articles for article (PubMed ID: 15634724)
21. Growth hormone treatment in short children born prematurely--data from KIGS.
Boguszewski MC; Karlsson H; Wollmann HA; Wilton P; Dahlgren J
J Clin Endocrinol Metab; 2011 Jun; 96(6):1687-94. PubMed ID: 21430029
[TBL] [Abstract][Full Text] [Related]
22. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
23. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
Ranke MB; Guilbaud O
Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
[TBL] [Abstract][Full Text] [Related]
24. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
[TBL] [Abstract][Full Text] [Related]
25. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
Carrascosa A; Audí L; Fernández-Cancio M; Esteban C; Andaluz P; Vilaró E; Clemente M; Yeste D; Albisu MA; Gussinyé M
J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
[TBL] [Abstract][Full Text] [Related]
26. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
[TBL] [Abstract][Full Text] [Related]
27. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
[TBL] [Abstract][Full Text] [Related]
28. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
[TBL] [Abstract][Full Text] [Related]
29. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data.
Bonfig W; Lindberg A; Carlsson M; Cutfield W; Dunger D; Camacho-Hübner C; Holl RW
J Pediatr; 2018 Jul; 198():260-264. PubMed ID: 29656861
[TBL] [Abstract][Full Text] [Related]
31. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
Ranke MB; Lindberg A; Martin DD; Bakker B; Wilton P; Albertsson-Wikland K; Cowell CT; Price DA; Reiter EO
J Clin Endocrinol Metab; 2003 Oct; 88(10):4748-53. PubMed ID: 14557450
[TBL] [Abstract][Full Text] [Related]
32. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
[TBL] [Abstract][Full Text] [Related]
33. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA;
J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
35. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
37. Reference curve for the first-year growth response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency: validation of the KIGS first-year growth response curve using the Belgian Register for the Study of Growth and Puberty Problems.
Straetemans S; Roelants M; Thomas M; Rooman R; De Schepper J
Horm Res Paediatr; 2014; 81(5):343-9. PubMed ID: 24686034
[TBL] [Abstract][Full Text] [Related]
38. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
39. Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency.
Blethen SL; Compton P; Lippe BM; Rosenfeld RG; August GP; Johanson A
J Clin Endocrinol Metab; 1993 Mar; 76(3):574-9. PubMed ID: 8445013
[TBL] [Abstract][Full Text] [Related]
40. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
